Vertex Minerals continues to steadily increase the rate of stoping at Reward gold mine, delivering ore grade material and ...

Analysts project the U.S. diabetes market will surge past $75 billion by 2031, driven by advanced cell therapies and continuous glucose monitoring systems transforming patient care [3]. Regenerative ...

Data presented at ASH suggest that the CRISPR therapy could provide a one-time functional cure in children as young as 5 years old, researchers said.

KING OF PRUSSIA, Pa., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ: VERX) (“Vertex” or the “Company”), a leading global provider of indirect tax solutions, today announced financial results ...

Vertex Announces Third Quarter 2025 Financial Results And $150 Million Class A Common Stock Repurchase Program. KING OF PRUSSIA, Pa., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ: VERX) ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced several important updates across its development program for povetacicept (pove), an investigational recombinant fusion protein ...

As a long-time Oracle partner, Vertex will continue to leverage Oracle technologies to drive customer success globally KING OF PRUSSIA, June 10, 2025(NASDAQ:VERX) ("Vertex" or the "Company"), a ...

Investing.com - H.C. Wainwright lowered its price target on Vertex Pharmaceuticals (NASDAQ: VRTX) to $478 from $550 while maintaining a Buy rating following setbacks in the company’s pain program.

NEW YORK and ROME, Ga., Aug. 5, 2025 /PRNewswire/ -- The VERTEX Companies, LLC ("VERTEX"), a global professional services firm delivering expert, forensic, construction project advisory, and ...